We identified a rate for KRAS and TP53 mutations (respectively 37% and 44%) as similar to that of CIN tumors but with an absence of BRAF mutations and no evidence of a methylator phenotype [41]. This evidence concerns the gene TP53 and cervical squamous intraepithelial neoplasia.